11 / 12
Page 31
Notes:
Ann Clin Trials Vaccines Res. 2017 | Volume 1 Issue 2
allied
academies
Global Vaccines & Vaccination Summit & B2B
November 01-02, 2017 | Toronto, Canada
Statement of the Problem:
Although the decision making
for vaccination strategies is done individually, it is influenced
by social and public policies. Over the last years, the Brazilian
National Immunization Program (PNI) has registered a 95% rate
of national vaccination coverage, which is similar to the rates
observed in developed countries. The current challenges to be
overcome by the program in order to preserve its excellence
are to maintain its high rates of vaccination coverage, access
equality, vaccination coverage monitoring, and safety, among
others. The aim of this work is to analyze the development of
the PNI program over the last decades along with its challenges
and prospects for modernization and improvement.
Methodology & Theoretical Orientation:
The research
methodology used in this work was of descriptive and
bibliographical survey based on the Brazilian population data.
The collection of data occurred between May and June of 2017
in the city of Rio de Janeiro - RJ - Brazil. Over the last years there
has been a decrease in the rate of hospital admissions for the
following diseases: measles, meningitis, tetanus, influenzas,
pneumonia and others. Nevertheless, the access to information
remains fragmented due to low informatization levels of the
processes.
Conclusions:
The investments made in immunization generates
countless benefits to the healthcare system and, consequently,
to the health of Brazilians. Despite the high vaccination rates,
the PNI program still needs improvements, especially in terms
of modernization and informatization of the healthcare system.
Nevertheless, its effective implementation demands investments
for the acquisition and maintenance of new technologies, training
of professionals, anorganizational change, certification criteria and
interoperability standards. Additionally, one of themain challenges
for the PNI program is to align the strategies of verification and
monitoring of disease risk perception and adverse events following
vaccination (AEFV) among the different agents involved.
Speaker Biography
Ricardo Bordinhao has received his Bachelor’s degree in Pharmacy from the
Universidade do Grande Rio - Unigranrio in 2001 and is currently obtaining a degree in
Logistics Management and Pharmaceutical Distribution from the Institute of Science,
Technology and Quality - ICTQ. He has worked in the pharmaceutical department
of a number of renowned hospitals in Rio de Janeiro, developing great expertise in
integration and consultancy for ANVISA regulatory matters. He is a Member of the
Ethics Committee and of the Technical Chamber for Pharmaceutical Logistics of the
Regional Pharmacy Council of Rio de Janeiro. He currently works at BRL-Distribuidora
De Vacinas Ltda, a Pharmaceutical and Drug distributor where he holds the position of
Logistics Manager and Head Pharmacy Technician.
e:
ricardo@farmaceuticovirtual.com.brRicardo Bordinhao
BRL-Distribuidora de Vacinas LTDA, Brazil
The Brazilian national immunization program and its challenges for modernization
and improvement